Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe

European Journal of Clinical Pharmacology

Volumn 60, Issue 7, 2004, Pages 503-511

  Walley, T ^a   Folino Gallo, P ^b   Schwabe, U ^c   Van Ganse, E ^d   Stephens, P ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Istituto Di Ricerche Sulla Popolazione E Le Politiche Sociali Rome   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITÉ LYON 1   (France)

^e IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CLINICAL OBSERVATION; COMMERCIAL PHENOMENA; DATA ANALYSIS; DATA BASE; DIAGNOSTIC VALUE; DRUG COST; DRUG MARKETING; DRUG UTILIZATION; DYSLIPIDEMIA; EUROPE; EUROPEAN UNION; GOVERNMENT; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NORWAY; PRIORITY JOURNAL; PUBLIC HEALTH;

DATABASES, FACTUAL; DRUG COSTS; EUROPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PHARMACOEPIDEMIOLOGY; REPRODUCIBILITY OF RESULTS;

EID: 5344279086     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0801-9     Document Type: Article

References (14)

1. European Health for All Database, WHO, January 2003 Available at http://www.euro.who.int/InformationSources/Data/20010827_1 (accessed 29th April 2003)
2. Sudlow C, Lonn E, Pignone M, Ness A, Rihal C (2003) Secondary prevention of ischaemic cardiac events. In: Clinical evidence, BMJ Books, London
3. The EURO-MED-STAT Group (2003) EURO-MED-STAT: monitoring expenditure and utilisation of medicinal products in the European Union countries. A public health approach. Eur J Pub Health 13(3):95-100
4. Walley T, Folino-Gallo P, Schwabe U, Van Ganse E (2004) Variations and increase in use of statins across Europe: data from administrative databases. BMJ 328:385-386
5. General Medical Services Payments Board (2002) Financial and statistical analysis of claims and payments. Government Publications Office, Dublin
6. WHO Collaborating Centre for Drug Statistics Methodology (2000) ATC index with DDDs 2000, Oslo
7. Anon (2001) Il consume di staline a livello internazionale e nel contesto italiano. Bollettino di Informazione sui Farmaci (BIF) 4-5:194-201
8. Anon (2004) The price you are forced to pay. The Irish Times, 27 January 2004
9. Danzon PM, Kim JD (1998) International price comparisons for pharmaceuticals. Measurement and policy issues. Pharmacoeconomics 14 [Suppl 1]:115-128
10. EuroMedStat at http://www.euromedstat.cnr.it/project/project.asp
11. Walley T, Roberts D (2000) Average daily quantities - a tool for measuring prescribing volume in England. Pharmacoepidemiol Drug Safety 9:55-58
12. Illingworth DR, Erkelens DW, Keller U, Thompson GR, Tikkanen MJ Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet 343:1554-1555
13. Folino-Gallo P et al (2003) L'assistenza farmaceutica territoriale. In: Folino-Gallo P, Ricciardi G (eds) Osservasalute report 2003. Vita and Pensiero, Milan
14. Feely J, McGettigan P, Kelly A (2000) Growth in use of statins after trials is not targeted to most appropriate patients. Clin Pharmacol Ther 67:438-441